Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
April 3, 2018
Patent Application Number
14421845
Date Filed
September 12, 2013
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present application relates to nucleic acid compounds, compositions comprising same and methods of use thereof for treatment of various diseases, disorders and conditions. The compounds are preferably chemically synthesized and modified double-stranded nucleic acid molecules which down regulate expression of a p53 gene.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
